Psychosocial stress and liver disease status

World Journal of Gastroenterology

Volumn 15, Issue 24, 2009, Pages 2980-2986

  Vere, Cristin Constantin ^a   Teodor Streba, Costin ^b   Streba, Letticia Maria ^c   Ionescu, Alin Gabriel ^a   Sima, Felix ^a  

^a Emergency County Hospital of Craiova   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c 3rd Department of Internal Medicine   (Romania)

Author keywords

Carcinoma; Chronic viral hepatitis; Cirrhosis; Hepatocellular; Liver pathology; Stress

Indexed keywords

ADRENERGIC SYSTEM; CELL FUNCTION; DISEASE COURSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MENTAL STRESS; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; VIRUS HEPATITIS;

EID: 67651247396     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2980     Document Type: Review

References (90)

1. Cohen S, Kessler RC, Gordon LU. Strategies for measuring stress in studies of psychiatric and physical disorders. In: Cohen S, Kessler RC, Gordon LU, editors. Measuring stress: A guide for health and social scientists. New York: Oxford University Press, 1995: 3-26
2. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004; 130: 601-630
3. Swain MG. I. Stress and hepatic inflammation. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1135-G1138
4. Hirose S, Hirayama C, Ikemi Y. The influence of emotional stress on the liver blood flow. Kyushu J Med Sci 1961; 12: 319-323
5. Kaplan MH, Wheeler WF. Stress and diseases of the upper gut. I. Stress and liver disease. Mt Sinai J Med 1983; 50: 225-227
6. Chida Y, Sudo N, Kubo C. Does stress exacerbate liver diseases? J Gastroenterol Hepatol 2006; 21: 202-208
7. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252
8. Chrousos GP. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. Endocrinol Metab Clin North Am 1992; 21: 833-858
9. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W. The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 1993; 172: 5-21; discussion 21-29
10. Saper CB, Loewy AD, Swanson LW, Cowan WM. Direct hypothalamo-autonomic connections. Brain Res 1976; 117: 305-312
11. Larsen PJ, Jessop D, Patel H, Lightman SL, Chowdrey HS. Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J Neuroendocrinol 1993; 5: 99-105
12. Culman J, Tschope C, Jost N, Itoi K, Unger T. Substance P and neurokinin A induced desensitization to cardiovascular and behavioral effects: evidence for the involvement of different tachykinin receptors. Brain Res 1993; 625: 75-83
13. Jessop DS, Chowdrey HS, Larsen PJ, Lightman SL. Substance P: multifunctional peptide in the hypothalamo-pituitary system? J Endocrinol 1992; 132: 331-337
14. Nikolarakis KE, Almeida OF, Herz A. Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro). Brain Res 1986; 399: 152-155
15. Burns G, Almeida OF, Passarelli F, Herz A. A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins. Endocrinology 1989; 125: 1365-1372
16. Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocrinol Metab 1984; 58: 298-303
17. Rittmaster RS, Cutler GB Jr, Gold PW, Brandon DD, Tomai T, Loriaux DL, Chrousos GP. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. J Clin Endocrinol Metab 1987; 64: 371-376
18. Elkabir DR, Wyatt ME, Vellucci SV, Herbert J. The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat. Regul Pept 1990; 28: 199-214
19. Calogero AE, Norton JA, Sheppard BC, Listwak SJ, Cromack DT, Wall R, Jensen RT, Chrousos GP. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. Metabolism 1992; 41: 839-845
20. Hinson JP. Paracrine control of adrenocortical function: a new role for the medulla? J Endocrinol 1990; 124: 7-9
21. Andreis PG, Neri G, Mazzocchi G, Musajo F, Nussdorfer GG. Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zona medullaris. Endocrinology 1992; 131: 69-72
22. Vinson GP, Whitehouse BJ, Henvill KL. The actions of alpha-MSH on the adrenal cortex. In: Hadley ME, editor. The actions of a-MSH on the adrenal cortex, the melanotropic peptides. Vol. II. Biological roles. Boca Raton, Fla.: CRC Press, 1988: 87-133
23. Ottenweller JE, Meier AH. Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology 1982; 111: 1334-1338
24. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198-1208
25. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993; 119: 1113-1124
26. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89: 9991-9995
27. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11: 443-449
28. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989; 69: 1-32
29. Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989; 10: 92-112
30. Schafer M, Carter L, Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994; 91: 4219-4223
31. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991; 254: 421-423
32. Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP, Wilder RL. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest 1992; 90: 2555-2564
33. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, Mathern P, Chrousos GP, Wilder RL. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol 1993; 151: 1587-1596
34. Scopa CD, Mastorakos G, Friedman TC, Melachrinou M, Merino MJ, Chrousos GP. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. Am J Pathol 1994; 145: 1159-1167
35. Patchev VK, Mastorakos G, Brady LS, Redwine J, Wilder RL, Chrousos GP. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 1993; 58: 106-110
36. Stephanou A, Jessop DS, Knight RA, Lightman SL. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 1990; 4: 67-73
37. Ekman R, Servenius B, Castro MG, Lowry PJ, Cederlund AS, Bergman O, Sjogren HO. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J Neuroimmunol 1993; 44: 7-13
38. Aird F, Clevenger CV, Prystowsky MB, Redei E. Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc Natl Acad Sci USA 1993; 90: 7104-7108
39. Woods RJ, Grossman A, Saphier P, Kennedy K, Ur E, Behan D, Potter E, Vale W, Lowry PJ. Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J Clin Endocrinol Metab 1994; 78: 73-76
40. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362
41. Nagano J, Nagase S, Sudo N, Kubo C. Psychosocial stress, personality, and the severity of chronic hepatitis C. Psychosomatics 2004; 45: 100-106
42. Grossarth-Maticek R, Eysenck HJ. Personality, stress and disease: description and validation of a new inventory. Psychol Rep 1990; 66: 355-373
43. Kunkel EJ, Kim JS, Hann HW, Oyesanmi O, Menefee LA, Field HL, Lartey PL, Myers RE. Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics 2000; 41: 472-480
44. Jabaaij L, van Hattum J, Vingerhoets JJ, Oostveen FG, Duivenvoorden HJ, Ballieux RE. Modulation of immune response to rDNA hepatitis B vaccination by psychological stress. J Psychosom Res 1996; 41: 129-137
45. Burns VE, Carroll D, Ring C, Harrison LK, Drayson M. Stress, coping, and hepatitis B antibody status. Psychosom Med 2002; 64: 287-293
46. Marsland AL, Cohen S, Rabin BS, Manuck SB. Trait positive affect and antibody response to hepatitis B vaccination. Brain Behav Immun 2006; 20: 261-269
47. Fukudo S, Suzuki J, Tanaka Y, Iwahashi S, Nomura T. Impact of stress on alcoholic liver injury; a histopathological study. J Psychosom Res 1989; 33: 515-521
48. Kaji I, Sekiya C. NamikI M. Psychosomatic study of the patients with liver disorders: including an experimental study. Jap J psychosom Med 1981; 21: 302-312
49. Chida Y, Sudo N, Sonoda J, Sogawa H, Kubo C. Electric foot shock stress-induced exacerbation of alpha-galactosylceramide-triggered apoptosis in mouse liver. Hepatology 2004; 39: 1131-1140
50. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192: 921-930
51. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, Nakayama T, Taniguchi M, Bendelac A, Van Kaer L, Koezuka Y, Tsuji M. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 2000; 97: 8461-8466
52. Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, Abrignani S. Dynamics of intrahepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998; 28: 3448-3455
53. Ishigami M, Nishimura H, Naiki Y, Yoshioka K, Kawano T, Tanaka Y, Taniguchi M, Kakumu S, Yoshikai Y. The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice. Hepatology 1999; 29: 1799-1808
54. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278: 1626-1629
55. Osman Y, Kawamura T, Naito T, Takeda K, Van Kaer L, Okumura K, Abo T. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur J Immunol 2000; 30: 1919-1928
56. Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 2001; 166: 6578-6584
57. Tamada K, Harada M, Abe K, Li T, Nomoto K. IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance. J Immunol 1998; 161: 1239-1247
58. Tjandra K, Kubes P, Rioux K, Swain MG. Endogenous glucocorticoids inhibit neutrophil recruitment to inflammatory sites in cholestatic rats. Am J Physiol 1996; 270: G821-G825
59. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger MJ. Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver. Am J Physiol 1995; 268: R699-R706
60. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232: 977-980
61. Tanaka K, Sakai H, Hashizume M, Hirohata T. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res 1998; 89: 1241-1250
62. Iwai M, Saheki S, Ohta Y, Shimazu T. Foot-shock stress accelerates carbon tetrachloride-induced liver injury in rats: implication of the sympathetic nervous system. Biomed Res (Tokyo) 1986; 7: 145-154
63. Swain MG, Appleyard C, Wallace J, Wong H, Le T. Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release. Am J Physiol 1999; 276: G199-G205
64. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220
65. Aldrighetti L, Pulitane C, Arru M, Finazzi R, Catena M, Soldini L, Comotti L, Ferla G. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transpl 2006; 12: 941-949
66. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 1996; 108: 374-381
67. Tjandra K, Sharkey KA, Swain MG. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology 2000; 31: 280-290
68. Kitamura H, Konno A, Morimatsu M, Jung BD, Kimura K, Saito M. Immobilization stress increases hepatic IL-6 expression in mice. Biochem Biophys Res Commun 1997; 238: 707-711
69. Jung BD, Kimura K, Kitamura H, Makondo K, Okita K, Kawasaki M, Saito M. Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes. J Biochem 2000; 127: 205-209
70. Kajiyama Y, Ui M. Switching from alpha 1- to beta-subtypes in adrenergic response during primary culture of adult-rat hepatocytes as affected by the cell-to-cell interaction through plasma membranes. Biochem J 1994; 303 (Pt 1): 313-321
71. Hasko G, Szabo C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol 1998; 56: 1079-1087
72. Jacob LS. Sympathomimetic agents. In: Jacob LS, editor. Pharmacology. 4th ed. Maryland: Williams & Wilkins, 1996: 22-30
73. Nakajima T, Mizushima N, Kanai K. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver. Jpn J Clin Oncol 1987; 17: 327-332
74. Steel J, Carney M, Carr BI, Baum A. The role of psychosocial factors in the progression of hepatocellular carcinoma. Med Hypotheses 2004; 62: 86-94
75. Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol 1994; 49: 389-404
76. Steplewski Z, Vogel WH, Ehya H, Poropatich C, Smith JM. Effects of restraint stress on inoculated tumor growth and immune response in rats. Cancer Res 1985; 45: 5128-5133
77. Bagenal FS, Easton DF, Harris E, Chilvers CE, McElwain TJ. Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet 1990; 336: 606-610
78. Spiegel D, Kato PM. Psychosocial influences on cancer incidence and progression. Harv Rev Psychiatry 1996; 4: 10-26
79. Kiecolt-Glaser JK. Norman Cousins Memorial Lecture 1998. Stress, personal relationships, and immune function: health implications. Brain Behav Immun 1999; 13: 61-72
80. Ramirez AJ, Craig TK, Watson JP, Fentiman IS, North WR, Rubens RD. Stress and relapse of breast cancer. BMJ 1989; 298: 291-293
81. Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990; 47: 720-725
82. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993; 50: 681-689
83. Liu H, Wang Z. Effects of social isolation stress on immune response and survival time of mouse with liver cancer. World J Gastroenterol 2005; 11: 5902-5904
84. Sivonova M, Zitnanova I, Hlincikova L, Skodacek I, Trebaticka J, Durackova Z. Oxidative stress in university students during examinations. Stress 2004; 7: 183-188
85. Glaser R, Thorn BE, Tarr KL, Kiecolt-Glaser JK, D'Ambrosio SM. Effects of stress on methyltransferase synthesis: an important DNA repair enzyme. Health Psychol 1985; 4: 403-412
86. Kiecolt-Glaser JK, Stephens RE, Lipetz PD, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med 1985; 8: 311-320
87. Cohen L, Marshall GD Jr, Cheng L, Agarwal SK, Wei Q. DNA repair capacity in healthy medical students during and after exam stress. J Behav Med 2000; 23: 531-544
88. Forlenza MJ, Baum A. Psychosocial influences on cancer progression: alternative cellular and molecular mechanisms. Curr Opin Psychiatry 2000; 13: 639-645
89. Tomei LD, Kiecolt-Glaser JK, Kennedy S, Glaser R. Psychological stress and phorbol ester inhibition of radiation-induced apoptosis in human peripheral blood leukocytes. Psychiatry Res 1990; 33: 59-71
90. Blumberg PM. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res 1988; 48: 1-8